|
1
|
BNP |
NA: NA |
risk factor (article mentioned) |
|
2
|
SV |
NA: NA |
risk factor (article mentioned) |
|
12
|
non-Hispanic white |
NA: NA |
risk factor |
|
13
|
experiencing operating room (OR) time greater than 4 hours |
NA: NA |
risk factor |
|
14
|
having oxygen saturation levels less than 85% |
NA: NA |
risk factor |
|
15
|
average worse Braden QD scores per day |
NA: NA |
risk factor |
|
20
|
eduction (associate degree or higher) |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
risk factor |
|
49
|
poor sleep combined with daytime nap (simple CHD offspring) |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
risk factor |
|
50
|
poor sleep without daytime nap (simple CHD offspring) |
isolated CHD: ASD/VSD/PDA/PVS/AVS/CoA/PAS |
risk factor |
|
52
|
poor sleep combined with daytime nap (severe CHD offspring) |
isolated CHD: DORV/TGA/AVSD/TOF/HLHS/SV/TAPVR/TS |
risk factor |
|
53
|
poor sleep without daytime nap(severe CHD offspring) |
isolated CHD: DORV/TGA/AVSD/TOF/HLHS/SV/TAPVR/TS |
risk factor |
|
54
|
Arterial hypertension (percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(crude OR) |
|
58
|
Arterial hypertension (percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(article mentioned) |
|
59
|
Diabetes mellitus(percent) |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(article mentioned) |
|
60
|
Dyslipidemia |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(article mentioned) |
|
61
|
Smoking |
isolated CHD: AVD/PV/ASD/VSD/Ductus/other SAS/SVAS/CoA/Subvalvular or supravalvula PS/TOF/EA/AVSD/Sinus venosus SD/D-TGA/L-TGA/PA/SV/DORV/ES/TA/TAS |
risk factor(article mentioned) |
|
62
|
Chronic coronary artery disease: HR for cancer |
NA: NA |
risk factor |
|
63
|
Previous transplantationa status: HR for cancer |
NA: NA |
risk factor |
|
64
|
Chronic coronary artery disease: HR for all-cause mortality |
NA: NA |
risk factor |
|
65
|
Previous transplantationa status: HR for all-cause mortality |
NA: NA |
risk factor |
|
66
|
outcome of severe maternal morbidity |
|
risk factor |
|
70
|
outcome of ischemic placental disease |
isolated CHD: Complex anomalies of atrioventricular connections |
risk factor |
|
71
|
outcome of ischemic placental disease |
isolated CHD: FUVH |
risk factor |
|
72
|
outcome of ischemic placental disease |
isolated CHD: CACA |
risk factor |
|
73
|
severe neonatal morbidity and mortality |
|
risk factor |
|
74
|
perinatal mortality |
|
risk factor |
|
75
|
major visible congenital anomalies |
|
risk factor |
|
76
|
preterm birth<37 weeks |
|
risk factor |
|
77
|
preterm birth<32 weeks |
|
risk factor |
|
78
|
SGA birth |
|
risk factor |
|
88
|
fontan status (Predictors of Recurrence After First Catheter Ablation) |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
risk factor |
|
89
|
Prior surgical maze (Predictors of Recurrence After First Catheter Ablation) |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
risk factor |
|
90
|
Failed amiodarone (Predictors of Recurrence After First Catheter Ablation) |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
risk factor |
|
91
|
acute procedural success (Predictors of Recurrence After First Catheter Ablation) |
isolated CHD: ASD, VSD/AS, BAV/TOF, PS/AVC/ECD/EA/other |
risk factor |
|
100
|
Pericardial effusion |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
risk factor |
|
133
|
Age |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
134
|
weight |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
135
|
cross-clamp time (CCT) |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
136
|
cardiopulmonary bypass time (CPB) |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
138
|
pulmonary hypertension |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
139
|
impaired heart function |
isolated CHD: VSD/ASD/TOF/TGA/PDA/AVSD/AP/AS/DORV/PA/CoA/other |
risk factor (article mentioned) |
|
146
|
pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
148
|
pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
150
|
pre-pregnancy diabetes |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
152
|
maternal insulin use |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
154
|
maternal insulin use |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
156
|
paternal race (Hispanic foreign born) |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
158
|
paternal race (Hispanic U.S. born) |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
160
|
Pregnancies complicated by CHD with aortic obstruction (AO) |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
risk factor |
|
164
|
abnormal Placental Pathology |
isolated CHD/non-isolated CHD: TGA, IVS/TGA, VSD/TOF/TOF, PA/TA/TAPVC/EA/VSD, IAA/CoA, HAA/other/PA, IVS/HLHS/DORV/CoA |
risk factor |
|
165
|
moderate/severe brain leision |
isolated CHD/non-isolated CHD: TGA, IVS/TGA, VSD/TOF/TOF, PA/TA/TAPVC/EA/VSD, IAA/CoA, HAA/other/PA, IVS/HLHS/DORV/CoA |
risk factor |
|
175
|
Diastolic Blood Pressure(median[IQR] |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
176
|
BMI(median[IQR] |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
177
|
Obesity(%) |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
178
|
Diagnosed/Treated for Hypertension(%) |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
179
|
Diagnosed/Treated for Hyperlipidemia(%) |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
180
|
Diagnosed/Treated for Diabets(%) |
isolated CHD: IAVD/non-complex CHD |
risk factor (article mentioned) |
|
181
|
No events of Acute Coronary Syndrome(ACS) |
isolated CHD: IAVD |
risk factor |
|
182
|
No events of Acute Coronary Syndrome(ACS) |
isolated CHD: Non-complex defects |
risk factor |
|
183
|
No. events of Ischemic Stroke |
isolated CHD: IAVD |
risk factor |
|
184
|
No. events of Ischemic Stroke |
isolated CHD: Non-complex defects |
risk factor |
|
185
|
No. events of Heart Failure |
isolated CHD: IAVD |
risk factor |
|
186
|
No. events of Heart Failure |
isolated CHD: Non-complex defects |
risk factor |
|
187
|
No. events of Atrial Fibrillation(AF) |
isolated CHD: IAVD |
risk factor |
|
188
|
No. events of Atrial Fibrillation(AF) |
isolated CHD: Non-complex defects |
risk factor |
|
189
|
number of Cardiovascular Risk factors(Low<2) |
isolated CHD: IAVD |
risk factor |
|
190
|
number of Cardiovascular Risk factors(Low<2) |
isolated CHD: Non-complex defects |
risk factor |
|
191
|
number of Cardiovascular Risk factors(Intermediate Risk 3-4) |
isolated CHD: IAVD |
risk factor |
|
192
|
number of Cardiovascular Risk factors(Intermediate Risk 3-4) |
isolated CHD: Non-complex defects |
risk factor |
|
193
|
number of Cardiovascular Risk factors(Intermediate Risk >5) |
isolated CHD: IAVD |
risk factor |
|
194
|
number of Cardiovascular Risk factors(Intermediate Risk >5) |
isolated CHD: Non-complex defects |
risk factor |
|
203
|
Suspected sepsis(incidence rate) |
NA: NA |
risk factor |
|
204
|
exposure to calcineurin inhibitors(incidence rate) |
NA: NA |
risk factor |
|
205
|
vancomycin(incidence rate) |
NA: NA |
risk factor |
|
206
|
piperacillin-tazobactam(incidence rate) |
NA: NA |
risk factor |
|
207
|
a longer duration of mechanical ventilation |
NA: NA |
risk factor |
|
208
|
intensive care unit length of stay |
NA: NA |
risk factor |
|
210
|
Overweight patients: Lesion type complex |
NA: NA |
risk factor(article mentioned) |
|
213
|
Obese patients: Lesion type complex |
isolated CHD/non-isolated CHD: A-CHD/C-CHD/NA |
risk factor(article mentioned) |
|
214
|
Obese patients: Lesion type cyanotic |
isolated CHD/non-isolated CHD: A-CHD/C-CHD/NA |
risk factor(article mentioned) |
|
215
|
cold |
NA: NA |
risk factor |
|
216
|
depression scores |
NA: NA |
risk factor (article mentioned) |
|
217
|
cold with high depression scores |
NA: NA |
risk factor |
|
218
|
cold with lower depression scores |
NA: NA |
risk factor |
|
219
|
high depression scores |
NA: NA |
risk factor |
|
220
|
cold with high depression scores(withourt fever) |
NA: NA |
risk factor |
|
224
|
female sex |
isolated CHD: CHD with PAH |
risk factor |
|
229
|
menstruation |
isolated CHD: CHD with PAH |
risk factor |
|
254
|
taking drugs during perinatal period |
NA: NA |
risk factor |
|
255
|
taking cold medicine during perinatal period |
NA: NA |
risk factor |
|
256
|
taking antibotics during perinatal period |
NA: NA |
risk factor |
|
257
|
taking salicylates during perinatal period |
NA: NA |
risk factor |
|
258
|
taking antifungal drugs during perinatal period |
NA: NA |
risk factor |
|
259
|
taking two kinds of medicines |
NA: NA |
risk factor |
|
260
|
taking cold medicine in early pregnancy |
NA: NA |
risk factor |
|
261
|
taking antibotics in early pregnancy |
NA: NA |
risk factor |
|
262
|
taking salicylates in early pregnancy |
NA: NA |
risk factor |
|
263
|
taking antifungal drugs in early pregnancy |
NA: NA |
risk factor |
|
264
|
taking other drugs in early pregnancy |
NA: NA |
risk factor |
|
265
|
Overweight |
isolated CHD/non-isolated CHD: TOF, PS, DCRV/ccTGA/ASD, VSD |
risk factor (article mentioned) |
|
266
|
obese |
isolated CHD/non-isolated CHD: TOF, PS, DCRV/ccTGA/ASD, VSD |
risk factor (article mentioned) |
|
267
|
morbidly obese |
isolated CHD/non-isolated CHD: TOF, PS, DCRV/ccTGA/ASD, VSD |
risk factor (article mentioned) |
|
268
|
Fontan |
isolated CHD/non-isolated CHD: NA |
risk factor (article mentioned) |
|
280
|
cesarean |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
282
|
fetal intolerance of labor(FIOL) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
283
|
FIOL if underwent IOL(Induction of labor) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
284
|
FIOL if SGA (<10th%) birthweight |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
285
|
FIOL if SGA (10–90th%) birthweight |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
286
|
Maternal hospital transfer |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
287
|
Delivery at academic center |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
289
|
SGA birthweight (<10th%) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
290
|
Low birthweight (<2,500 g) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
291
|
NICU admission |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
292
|
Neonate transferred |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
293
|
Apgar 5-min score (<7) |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
294
|
Apgar 5-min score |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
295
|
Neonatal death |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
296
|
Infant death |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
297
|
Assisted ventilation |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
298
|
Surfactant administration |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
299
|
Antibiotics for suspected sepsis |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
303
|
Preterm birth <37 week |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
306
|
fetal intolerance of labor |
isolated CHD: C-CHD |
risk factor (article mentioned) |
|
328
|
PDW value |
isolated CHD: PA/TGA/DORV/SV/TOF/TA |
risk factor |
|
329
|
increase of MPV |
isolated CHD: PA/TGA/DORV/SV/TOF/TA |
risk factor |
|
330
|
increase of PDW |
isolated CHD: PA/TGA/DORV/SV/TOF/TA |
risk factor (article mentioned) |
|
333
|
death |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
risk factor (article mentioned) |
|
334
|
hospitalization |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
risk factor (article mentioned) |
|
335
|
new onset of arrhytnmias |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
risk factor (article mentioned) |
|
336
|
surgical |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
risk factor (article mentioned) |
|
356
|
premature birth-direct effect on executive dysfunction |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
risk factor |
|
357
|
male sex-direct effect on executive dysfunction |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
risk factor |
|
365
|
Low physical HRQoL-Female sex |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
risk factor |
|
366
|
Low mental HRQoL-Female sex |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
risk factor |
|
367
|
Impaired poor psychological adjustment-Female sex |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
risk factor |
|
372
|
Impaired poor psychological adjustment- number of significant life events |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
risk factor |
|
378
|
total number of central venous catheter (CVC) |
isolated CHD: HRHS/HLHS/other |
risk factor |
|
400
|
congenital diagnosis |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
401
|
NYHA class |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
402
|
cardiac medication |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
403
|
re-intervention |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
405
|
NT-proBNP |
isolated CHD: AS/AC/TOF/EA/AVSD/ccTGA/CHD with PAH/FUVH |
risk factor |
|
406
|
Abnormal brain activity |
NA: BVP/BVP-AAO/SV |
risk factor |
|
419
|
the mutant allete T of 5,10 methylenetetrahydrofolate reductase (MTHFR) C677T T |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
420
|
the mutant allete CT of 5,10 methylenetetrahydrofolate reductase (MTHFR) C677T CT |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
421
|
the mutant allete TT of 5,10 methylenetetrahydrofolate reductase (MTHFR) C677T TT |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
424
|
MTHFR(C677T)CT/(A1298C)AA |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
425
|
MTHFR(C677T)TT/(A1298C)AA |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
risk factor |
|
430
|
neurocognitive deficits |
NA: NA |
risk factor (article mentioned) |
|
447
|
intra-atrial re- entrant tachycardia(IART) different than isolated cavotricuspid isthmus(CTI) first procedure |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
448
|
intra-atrial re- entrant tachycardia(IART) different than isolated cavotricuspid isthmus(CTI) in all follow-up |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
449
|
PR interval >200 ms |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
450
|
Atrial fibrillation(AF) induction |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
451
|
Previous atrial fibrillation |
isolated CHD: GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
risk factor |
|
453
|
vasoactive-inotropic score (VIS) |
isolated CHD: TOF/AVC/CAT/HLHS/CoA, IAA/MR, AOR/PA/TAPVC/TGA/VSD/ASD/other |
risk factor |
|
468
|
positive family history |
NA: NA |
risk factor (article mentioned) |
|
469
|
consanguinity |
NA: NA |
risk factor (article mentioned) |
|
470
|
maternal diabetes |
NA: NA |
risk factor (article mentioned) |
|
471
|
antiepileptics use by the mother |
NA: NA |
risk factor (article mentioned) |
|
473
|
no folic acid used by the mother |
NA: NA |
risk factor (article mentioned) |
|
481
|
previous atrial fibrillation |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
482
|
transposition of great arteries(TGA) |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
483
|
systemic ventricle dilation |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
484
|
Moderate-to-severe dilation of systemic ventricle |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
486
|
Grade III degree of cardiac disease complexity |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
487
|
atrial fibrillation induction |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
490
|
RF success of IART different than isolated CTI dependent IART |
isolated CHD/non-isolated CHD: TOF/ASD/SV/SPF/other/VSD/ASD/EA/CHD with IART |
risk factor |
|
491
|
occupational statuses of the mothers (Blue collar) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/DORV/PDA/NA |
risk factor |
|
492
|
mothers' drug exposure during gestation |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/DORV/PDA/NA |
risk factor |
|
493
|
frequencies of MTHFR gene 677 TT genotype in the mothers |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/DORV/PDA/NA |
risk factor |
|
494
|
frequencies of MTHFR gene 677 TT genotype in CHD children |
isolated CHD: ASD |
risk factor |
|
495
|
frequencies of MTHFR gene 677 TT genotype in the mothers |
isolated CHD: TOF |
risk factor |
|
496
|
frequencies of MTHFR gene 677 TT genotype in the mothers |
isolated CHD: DORV |
risk factor |
|
497
|
frequencies of MTHFR gene 677 TT genotype in the mothers |
isolated CHD: PDA |
risk factor |
|
498
|
Genotypes of SNP rs2243890 A>G in RCAN1.4 promoter region |
NA: NA |
risk factor |
|
508
|
teacher reported attention problems |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
risk factor |
|
513
|
Median RDW |
NA: NA |
risk factor (article mentioned) |
|
539
|
Percent of Dementia Events without extracardiac defects |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/CoA/TOF/TGA/TA/other |
risk factor |
|
540
|
Percent of Dementia Events without acquired cardiovascular disease or diabetes mellitus |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/CoA/TOF/TGA/TA/other |
risk factor |
|
541
|
New York Heart Association functional class (patients in class 3 and 4) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PS/AOS/Bc/CoA/D-TGA/ccTGA/TOF/EA/other |
risk factor |
|
542
|
N-terminal proB-type natriuretic peptide levels >125 pg/mL(NT pro-BNP) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PS/AOS/Bc/CoA/D-TGA/ccTGA/TOF/EA/other |
risk factor |
|
546
|
altitude |
isolated CHD: PDA/ASD/VSD |
risk factor (article mentioned) |
|
551
|
CIAS(Childhood Illness Attitude Scales) |
NA: NA |
risk factor (article mentioned) |
|
552
|
CASI (Children’s Anxiety Sensitivity Index)score |
NA: NA |
risk factor (article mentioned) |
|
553
|
SCAS(Spence Children’s Anxiety Scale) total score |
NA: NA |
risk factor (article mentioned) |
|
569
|
major complication during interventional procedures |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
risk factor |
|
575
|
interventional procedures |
isolated CHD/non-isolated CHD: MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
risk factor |
|
584
|
CSF/ICV(intracranial volume) |
isolated CHD: SV |
risk factor (article mentioned) |
|
594
|
AhR p.Arg554Lys-Additive(Arg/Arg vs.Arg/Lys vs.Lys/Lys) |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
595
|
AhR p.Arg554Lys-Dominant(Lys/Lys and Arg/Lys vs.Arg/Arg) |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
597
|
maternal exposure combined with Arg/Arg |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
598
|
Lys/Lys and Arg/Lys without maternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
599
|
Lys/Lys and Arg/Lys combined with maternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
602
|
Lys/Lys and Arg/Lys without maternal somking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
603
|
Lys/Lys and Arg/Lys combined with maternal somking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
605
|
paternal exposure combined with Arg/Arg |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
606
|
Lys/Lys and Arg/Lys without paternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
607
|
Lys/Lys and Arg/Lys combined with paternal exposure |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
609
|
paternal smoking combined with Arg/Arg |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
610
|
Lys/Lys and Arg/Lys without paternal somking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
611
|
Lys/Lys and Arg/Lys combined with paternal somking |
isolated CHD: VSD/ASD/TOF/AVSD/DORV/TGA |
risk factor |
|
653
|
age at surgery <30 days |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
risk factor |
|
654
|
use of milrinone |
isolated CHD/non-isolated CHD: HLHS/DORV/TOF, PA/D-TGA/D-TGA, VSD/TGA/VSD, IAA/TA/PA/DORV, VSD/other |
risk factor |
|
655
|
NYHA class II |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
risk factor |
|
657
|
Eisenmenger syndrome(ES) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
risk factor |
|
659
|
respiratory failure |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
risk factor (article mentioned) |
|
668
|
presence of prosthetic material with recurrent IE |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
risk factor |
|
669
|
cerebral emboli |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
risk factor |
|
670
|
acute renal failure |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
risk factor |
|
671
|
death rate |
isolated CHD/non-isolated CHD: D-TGA/D-TGA, VSD, PS/D-TGA, VSD, PA/AVSD/VSD, TVR/VSD, BAV/mechanical AVR for BAV/BAV |
risk factor |
|
672
|
risk factor correlated with primary outcome: 2V-RV |
isolated CHD: C-CHD/1V/2V-RV/2V-LV |
risk factor |
|
673
|
risk factor correlated with primary outcome:: NYHA |
isolated CHD: C-CHD/1V/2V-RV/2V-LV |
risk factor |
|
674
|
risk event rate[B-type natriuretic peptide(BNP) level] |
isolated CHD: C-CHD/1V/2V-RV/2V-LV |
risk factor |
|
675
|
risk event rate[Sodium level] |
isolated CHD: C-CHD/1V/2V-RV/2V-LV |
risk factor |
|
687
|
Lactic acid post-operation |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
688
|
von Willebrand factor(vWF) activity pre-operation |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
689
|
vWF concentration pre-operation |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
692
|
single ventricle(SV) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
720
|
Cp(pulmonary artery compliance) |
isolated CHD: CHD with PAH/EA |
risk factor |
|
721
|
correlation with pulmonary artery compliance(Cp) and Heart rate |
isolated CHD: CHD with PAH/EA |
risk factor |
|
722
|
correlation with Cp and 6-MWD |
isolated CHD: CHD with PAH/EA |
risk factor |
|
723
|
correlation with Cp and pulmonary blood flow |
isolated CHD: CHD with PAH/EA |
risk factor |
|
724
|
correlation with Cp and PAR(pulmonary artery resistance) |
isolated CHD: CHD with PAH/EA |
risk factor |
|
726
|
Incedence of Death |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
727
|
Incedence of heart failure(HF) |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
728
|
new-onset stroke |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
729
|
stroke incidence of different defect |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
730
|
stroke incidence of different defect |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
731
|
stroke incidence of different age |
isolated CHD: ASD/TOF/VSD/UVH/TGA/BAV |
risk factor |
|
740
|
previous intracardiac repair |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
741
|
pulmonary regurgitation |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
742
|
pulmonary AV valve regurgitation |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
743
|
pulmonary ventricular dysfunction |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
744
|
single ventricle physiology |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
745
|
systemic right ventricle |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
746
|
severe pulmonary hypertension |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
747
|
univentricular physiology |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
748
|
Fontan procedure |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
749
|
complex CHD |
isolated CHD: LVOTO/ASD/VSD/CoA/TOF/D-TGA/DORV/AVSD/ccTGA/PA/SV/ES/EA |
risk factor |
|
758
|
Low folate≤11.33nmol/L |
NA: NA |
risk factor (article mentioned) |
|
759
|
High homocysteine Adult >15 μmol/l；child >10 μmol/l |
NA: NA |
risk factor (article mentioned) |
|
760
|
folate(nmol/L) |
NA: NA |
risk factor (article mentioned) |
|
761
|
homocysteine (μmol/l) |
NA: NA |
risk factor (article mentioned) |
|
762
|
MTHFR C677T polymorphic(TT+CT) |
NA: NA |
risk factor (article mentioned) |
|
763
|
MTRR A66G polymorphic(AG+GG) |
NA: NA |
risk factor |
|
764
|
MTHFR C677T polymorphic(TT+CT) and MTRR A66G polymorphic(AG+GG) |
NA: NA |
risk factor |
|
765
|
MTHFR C677T polymorphic(TT+CT) and MTRR A66G polymorphic(AG+GG) |
NA: NA |
risk factor |
|
766
|
low folate levels and MTR A2756G |
NA: NA |
risk factor |
|
767
|
low folate levels and MTHFR A1298C |
NA: NA |
risk factor |
|
768
|
low folate levels and MTRR A66G |
NA: NA |
risk factor |
|
769
|
high homocysteine and MTHFR C677T |
NA: NA |
risk factor |
|
770
|
high homocysteine and MTR A2756G |
NA: NA |
risk factor |
|
794
|
thoracotomies(n) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
796
|
oxygen saturation at rest(%) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
801
|
independent predictors of a restrictive lung pattern(thoracotomies) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
802
|
independent predictors of a restrictive lung pattern(Cyanosis) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
803
|
independent predictors of a restrictive lung pattern(Pacer) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
804
|
independent predictors of a restrictive lung pattern(Complexity) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
805
|
independent predictors of a restrictive lung pattern(Beta-blocker) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
809
|
independent predictors of an impaired exercise capacity(Thoracotomies) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
811
|
independent predictors of an impaired exercise capacity (cyanosis) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
812
|
independent predictors of an impaired exercise capacity (complexity) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
813
|
independent predictors of an impaired exercise capacity(beta-blocker) |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
867
|
predischarge SAVV regurgitation grade |
isolated CHD/non-isolated CHD: AVSD/ccTGA/MS, MR |
risk factor |
|
892
|
Cumulative incidence of CKD--5 years post-CS |
NA: NA |
risk factor (article mentioned) |
|
893
|
Cox regression--Overall CS-AKI and CKD |
NA: NA |
risk factor |
|
894
|
Cox regression--CS-AKI and CKD >1 yr post-CS |
NA: NA |
risk factor |
|
903
|
incidence rate oflow cardiac output syndrome n(%) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
risk factor(article mentioned) |
|
909
|
levels of cumulative fluid overload 2 days after surgery (x±s, %) |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/TOF, DORV/TGA/TAPVC/PA/other |
risk factor(article mentioned) |
|
965
|
GIT symptoms--Age at onset of symptoms (<6 month) (percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
risk factor(article mentioned) |
|
969
|
GIT symptoms--Age at onset of symptoms (<6 month) (percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
risk factor(article mentioned) |
|
973
|
GIT symptoms--Age at onset of symptoms (<6 month) (percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
risk factor(article mentioned) |
|
1017
|
Impaired mental HrQoL--Pacemaker |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1018
|
Impaired physical HrQoL--Pacemaker |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1019
|
Impaired exercise capacity--Pacemaker |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1020
|
Impaired physical HrQoL--Beta-blocker intake |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1021
|
Impaired exercise capacity--Beta-blocker intake |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1022
|
Impaired exercise capacity--Severity of heart defect |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1023
|
Impaired exercise capacity--Severity of heart defect |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
risk factor |
|
1040
|
Predictors of procedural failure--Fontan physiology |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor |
|
1041
|
Predictors of procedural failure--Non-Fontan single-ventricle physiology |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor(article mentioned) |
|
1042
|
Predictors of procedural failure--Atrial fibrillation |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor(univariable model) |
|
1043
|
Predictors of procedural failure--Spontaneous echocardiographic contrast |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor |
|
1045
|
Predictors of arrhythmia recurrence--Fontan physiology |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor |
|
1046
|
Predictors of arrhythmia recurrence--Prior Mustard procedure |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor(univariable model) |
|
1047
|
Predictors of arrhythmia recurrence--Atrial fibrillation |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor |
|
1048
|
Predictors of arrhythmia recurrence--Moderate-severe systemic ventricular dysfunction |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
risk factor(univariable model) |
|
1102
|
cTn-I 2 h PO > 14 ng/mL (cardiac troponin I) |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
risk factor |
|
1105
|
MR-proADM 24 h PO > 1.5 nmol/L |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
risk factor |
|
1168
|
Inotrope using--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
risk factor |
|
1169
|
Age--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
risk factor |
|
1171
|
PH--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
risk factor |
|
1174
|
Heart failure--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
risk factor |
|
1176
|
Inotrope using--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD, PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA, PAH/other |
risk factor |
|
1221
|
Aortic cross clamp time (ACC time)(min) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1222
|
Cardiopulmonary bypass time (min) |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1223
|
Increasing rate of Lac |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1224
|
Procalcitonin |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1225
|
Intraop. blood loss |
isolated CHD/non-isolated CHD: TOF/ASD, TI/TAPVC/VSD, ASD, PDA, PAH/TAPVC/PDA/VSD, LVOTO/ECD/SV/TGA/DAA/IAA/DORV/other |
risk factor |
|
1226
|
Age ⩾35 years |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1227
|
preoperative left ventricular dysfunction |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1228
|
history of arrhythmia |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1229
|
longer bypass time |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1230
|
higher Risk Adjustment for Congenital Heart Surgery-1(RACHS-1) category |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1231
|
perioperative vancomycin use |
isolated CHD: TOF/EA/PAPVC/L-TGA/AS/ASD/Shone's Complex/CACA/D-TGA/DCRV/PA, IVS/AVC/SAM/AR/ARA/AC/MR/PVS/VSD/DILV/DORV/HLHS/TR/TAS |
risk factor |
|
1234
|
prevalence of parent reported executive dysfunction |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1235
|
working memory dysfunction |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1236
|
behavior regulation index(shift) |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1237
|
Male Gender |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1238
|
premature birth (≤37 weeks) |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1239
|
CHD with aortic obstruction (AO) |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PA/TA/VSD/AVC/TA, IAA/VSD, CoA/CoA/AH/SV/PA, IVS/SV/HLHS/other |
risk factor |
|
1254
|
Infant mortality rate for CHD in different ethnic |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
risk factor |
|
1255
|
Mortality of CHD in the postneonatal (28-364 day) period in different ethnic |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
risk factor |
|
1256
|
Mortality of CHD in the neonatal (<28day) period |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
risk factor |
|
1257
|
African American–white disparity in postneonatal mortality rate due to CHD |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
risk factor |
|
1260
|
preoperative digoxin exposure |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1262
|
VSD closure |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1263
|
a common polymorphism in the gene encoding Connexin-40(GJA5-rs10465855-TT-genotype) |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1264
|
Junctional acceleration (JA) |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1265
|
intermittent conduction noted during complete AV block |
isolated CHD/non-isolated CHD: TOF/VSD/HLHS/ASD/CAVC |
risk factor |
|
1271
|
Percent of fQRS (fragment QRS) |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
risk factor |
|
1272
|
moderate/severe non-systemic ventricular dysfunction |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
risk factor |
|
1273
|
percent of prolonged QRS complexes (QRS ≥120ms) |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
risk factor |
|
1274
|
Percent of surgical procedures (≥3) |
isolated CHD: AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD |
risk factor |
|
1275
|
reintervention age |
isolated CHD: TOF/CAVC/PS/PA |
risk factor |
|
1276
|
reintervention time of valve type |
isolated CHD: TOF/CAVC/PS/PA |
risk factor |
|
1277
|
reintervention time of valve type |
isolated CHD: TOF/CAVC/PS/PA |
risk factor |
|
1278
|
number of offspring with CHD(mother with diabetes mellitus, type 1) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1279
|
number of offspring with CHD(mother with diabetes mellitus, type 2) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1280
|
number of offspring with CHD(mothers with hypertension) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1281
|
number of offspring with CHD(mothers with congenital heart defects) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1282
|
number of offspring with CHD(mothers with anemia) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1283
|
number of offspring with CHD(mothers with connective tissue disorders) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1284
|
number of offspring with CHD(mothers with epilepsy) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1285
|
number of offspring with CHD(mothers with mood disorders) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1286
|
prevalence of severe CHD(mothers with diabetes mellitus type 2) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1287
|
prevalence of severe CHD(mothers with congenital heart defects) |
isolated CHD/non-isolated CHD: ASD/PDA/VSD/PS/CoA/ECD/AS/EA/other/TOF/TGA/DORV/TAPVR/Common ventricle/HLHS/Common truncus/TA/ccTGA |
risk factor |
|
1288
|
Wechsler Intelligence Scales:Verbal Comprehension of early-term birth |
isolated CHD: SV |
risk factor(article mentioned) |
|
1289
|
GEC T score(Brief parent-report) of early-term birth |
isolated CHD: SV |
risk factor(article mentioned) |
|
1296
|
Parent corrers' scaning ADHD Index T score |
isolated CHD: SV |
risk factor |
|
1308
|
longer hospital stay |
isolated CHD/non-isolated CHD: SV/TOF/TGA/PVS/MVA/AVA/other |
risk factor |
|
1313
|
patients with QRS ≥180 ms |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
risk factor (article mentioned) |
|
1322
|
absolute QRS duration |
isolated CHD/non-isolated CHD: TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
risk factor (article mentioned) |
|
1330
|
QRS duration >=5ms/year |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1331
|
Change from any baseline systemic ventricular function to severe ventricular dysfunction over time |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1332
|
Impairment of SVF (systemic ventricular function) p/y |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1333
|
Impairment of SVF ≥1 point p/y |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1334
|
Impairment of SPVF (subpulmonary ventricular function) ≥1 point p/y |
isolated CHD: ES/TGA/TOF/LSOD/ASD/VSD/AVSD/Cyanotic non-ES/EA/other |
risk factor |
|
1351
|
Cardiac events before pregnancy |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1352
|
New York Heart Association(NYHA) functional class >II |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1353
|
Moderate or severe PAH (Systolic pressure ≥50 mm Hg.) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1354
|
Left heart obstruction |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1355
|
Oxygen saturation <90% |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
risk factor |
|
1386
|
cardiac related hospitalizations |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
risk factor |
|
1387
|
cardiac interventions |
isolated CHD: TOF/EA/ASD/L-TGA/D-TGA/PS/other |
risk factor |
|
1420
|
metabolic syndrome criteria met(after matched control) |
isolated CHD: TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
risk factor |
|
1422
|
long donor heart ischemic time |
isolated CHD/non-isolated CHD: DORV, VSD/TOF/TGA/DOLV, PS/DILV, TGA, PS/ALVT/EA/DILV, VSD, PS/DORV, TGA, VSD, PS/ccTGA/VSD, CoA, PLSVC/PA, VSD/TGA, VSD/DORV, VSD, ASD, PS |
risk factor (article mentioned) |
|
1423
|
right ventricular assist device(RVAD) |
isolated CHD/non-isolated CHD: DORV, VSD/TOF/TGA/DOLV, PS/DILV, TGA, PS/ALVT/EA/DILV, VSD, PS/DORV, TGA, VSD, PS/ccTGA/VSD, CoA, PLSVC/PA, VSD/TGA, VSD/DORV, VSD, ASD, PS |
risk factor (article mentioned) |
|
1424
|
cTnT |
isolated CHD/non-isolated CHD: HLHS/AVSD/PA, IVS/HRHS |
risk factor (article mentioned) |
|
1425
|
NT pro-BNP |
isolated CHD/non-isolated CHD: HLHS/AVSD/PA, IVS/HRHS |
risk factor (article mentioned) |
|
1428
|
risk of neonatal death according to the cord blood concentrations of NT pro-BNP and cTnT |
isolated CHD/non-isolated CHD: HLHS/AVSD/PA, IVS/HRHS |
risk factor (article mentioned) |
|
1464
|
mortality |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
risk factor |
|
1465
|
previous cardiac surgery |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
risk factor |
|
1495
|
serum glucose |
isolated CHD: TOF |
risk factor |
|
1497
|
proportion of male |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1498
|
current smoking |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1500
|
problematic alcohol use |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1501
|
with exercise |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1502
|
surgically corrected ACHD |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1504
|
age |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1505
|
proportion of male |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1506
|
current smoking |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1508
|
problematic alcohol use |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1509
|
exercise |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
risk factor |
|
1512
|
log10 NT pro-BNP |
isolated CHD: PA/ccTGA/VSD/NA/SV/ES/PAH/CoA/EA/TGA/TOF/ASD/AVSD/TA/PS/AVD |
risk factor |
|
1514
|
GDF-15 level in age |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
risk factor |
|
1523
|
GDF-15 |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
risk factor |
|
1525
|
Age |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1526
|
Gender (% female) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1527
|
Complexity--Complex disease |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1528
|
NYHA class--Class III |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1529
|
NYHA class--Class IV |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(article mentioned) |
|
1540
|
Age (per decade) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(Univariate analysis) |
|
1541
|
Female sex |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor |
|
1542
|
NYHA class>2 |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(Univariate analysis) |
|
1543
|
Complex disease |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor |
|
1544
|
Anti-arrhythmic therapy |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(Univariate analysis) |
|
1545
|
Heart failure medication |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor(Univariate analysis) |
|
1546
|
survival propability |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/TGA/ccTGA/EA/ES/other |
risk factor |
|
1563
|
Dextrocardia |
isolated CHD/non-isolated CHD: TGA, VSD/PA, VSD/AVSD, ccTGA, MA/CoA, VSD/D-TGA, VSD/ccTGA/DORV, MA, PS/TAPVR |
risk factor |
|
1564
|
Correlation between socioeconomic status and Total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1565
|
Correlation between RACHS-1 score and total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1566
|
Correlation between antegrade cerebral perfusion and total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1567
|
Correlation between Length of ICU stay (d) and Total IQ |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1568
|
Correlation between RACHS-1 score and M-ABC-2 percentile rank |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/HAA, CoA/TGA/TOF/PA/DORV/TAPVD/HLHS/DILV/TA/other |
risk factor |
|
1572
|
Intercept(Regression of maximum exercise time to independent variables) |
NA: NA |
risk factor |
|
1576
|
Maximum HR(heart rate)(Regression of maximum exercise time to independent variables) |
NA: NA |
risk factor |
|
1577
|
Intercept(Regression of VE/VCO2 at peak exercise to independent variables) |
NA: NA |
risk factor |
|
1578
|
Severity(Regression of VE/VCO2 at peak exercise to independent variables) |
NA: NA |
risk factor |
|
1582
|
age less than 1 year(risk factors for early-phase mortality) |
isolated CHD: HLHS/other |
risk factor |
|
1583
|
prolonged cardiopulmonary bypass(risk factors for early-phase mortality) |
isolated CHD: HLHS/other |
risk factor |
|
1584
|
age more than 1 year(risk factors for late-phase mortality) |
isolated CHD: HLHS/other |
risk factor |
|
1585
|
donor-recipient race mismatch(risk factors for late-phase mortality) |
isolated CHD: HLHS/other |
risk factor |
|
1601
|
Depressive symptoms--Yes/No |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
risk factor |
|
1602
|
History of smoking tobacco use--Yes/No |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
risk factor |
|
1603
|
Advised to seek/history of mental health counseling--Yes/No |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
risk factor |
|
1615
|
odd ratios of CHD by Total-Age (0-<1 months) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1616
|
odd ratios of CHD by Total-Age (1-<2 months) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1617
|
odd ratios of CHD by Total-Age (2-<3 months) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1618
|
odd ratios of CHD by Total- Birthweight(<2500 g) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1619
|
odd ratios of CHD by Total- Birthweight( 2500-<3000g) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1620
|
odd ratios of CHD by Total- Gestational age (37 weeks) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1621
|
odd ratios of CHD by Maternal characteristics Age (≥40 years) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1622
|
odd ratios of CHD by Pregnant infection |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1623
|
odd ratios of CHD by Pregnancy-induced hypertension |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1624
|
odd ratios of CHD by Gestational diabetes |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1625
|
odd ratios of CHD by History of mother with CHD |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1626
|
odd ratios of CHD by History of father with CHD (Yes) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1627
|
odd ratios of CHD by Education of mother (<13 years) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1628
|
odd ratios of CHD by Family income (<1000 yuan/month) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/PS/TOF/AVSD/AS/SV/EA/NA |
risk factor |
|
1685
|
SNPs in mothers: MTHFR gene rs1801131:CC |
NA: NA |
risk factor |
|
1686
|
SNPs in mothers: MTHFR gene rs1801131:AA+AC |
NA: NA |
risk factor |
|
1693
|
SNPs in children: MTHFR gene rs1801131:AC |
NA: NA |
risk factor |
|
1694
|
SNPs in children: MTHFR gene rs1801131:AC+CC |
NA: NA |
risk factor |
|
1695
|
SNPs in children: MTHFR gene rs1801131:AA:AC:CC |
NA: NA |
risk factor |
|
1759
|
Bradyarrhythmia receiving intervention during entire postoperative course |
NA: NA |
risk factor |
|
1837
|
longer aortic cross clamping time |
isolated CHD/non-isolated CHD: HOCM, SAS, DCRV/VSD/D-TGA, VSD, PS, TVD/MS/DORV, TGA, VSD/ccTGA, PA, VSD/AVSD/AA, VSD, ASD, CoA |
risk factor(article mentioned) |
|
1839
|
surgical procedures including closure of VSD |
isolated CHD/non-isolated CHD: HOCM, SAS, DCRV/VSD/D-TGA, VSD, PS, TVD/MS/DORV, TGA, VSD/ccTGA, PA, VSD/AVSD/AA, VSD, ASD, CoA |
risk factor |
|
1853
|
age |
NA: NA |
risk factor |
|
1854
|
age at ICD implantation |
NA: NA |
risk factor |
|
1855
|
appropriate ICD shocks |
NA: NA |
risk factor |
|
1858
|
correlation between CHD(>28 days) and childhood stroke |
NA: NA |
risk factor |
|
1859
|
History of CHD repair surgery |
NA: NA |
risk factor |
|
1860
|
Cyanotic heart disease |
NA: C-CHD |
risk factor |
|
1863
|
Time from surgery(not in prior 14 days) |
NA: NA |
risk factor |
|
1865
|
mental stress during early pregnancy |
isolated CHD: ASD/VSD/other |
risk factor |
|
1866
|
pregnancy malnutrition during pregnancy |
isolated CHD: ASD/VSD/other |
risk factor |
|
1867
|
with abnormal childbearing history |
isolated CHD: ASD/VSD/other |
risk factor |
|
1869
|
diagnosis of single-ventricle heart defect |
isolated CHD: HLHS/TA/HRV/other/PS/CoA/TOF/IAA/PA/TGA/TA/AVS/EA/DORV |
risk factor |
|
1873
|
VSD |
isolated CHD: VSD |
risk factor |
|
1874
|
PDA |
isolated CHD: PDA |
risk factor |
|
1875
|
combined lesions |
non-isolated CHD: NA |
risk factor |
|
1877
|
HFSS with arrhythmia requiring treatment |
isolated CHD/non-isolated CHD: TOF/RV/EA/other |
risk factor |
|
1878
|
HFSS with CV hospitalizations |
isolated CHD/non-isolated CHD: TOF/RV/EA/other |
risk factor |
|
1879
|
HFSS with the composite |
isolated CHD/non-isolated CHD: TOF/RV/EA/other |
risk factor |
|
1891
|
Procedure-type categories 3 |
isolated CHD: PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
risk factor |
|
1892
|
Procedure-type categories 4 |
isolated CHD: PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
risk factor |
|
1926
|
the history of aorto-pulmonary shunt |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
risk factor |
|
1927
|
the direct aortic surgery |
isolated CHD: TOF/SV/AC/IAA/VSD/ASD/TGA/EA/ccTGA/TA/other |
risk factor |
|
1930
|
hospitalization stay length |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1931
|
combined use of antibiotics |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1932
|
systemic use of hormones |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1933
|
mechanical ventilation |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1934
|
catheter indwelling |
isolated CHD: VSD/ASD/PS/PDA/TOF/other |
risk factor |
|
1950
|
predictor of unscheduled hospitalization: SV systolic function |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1952
|
predictor of unscheduled hospitalization: Diuretics |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1953
|
predictor of unscheduled hospitalization: Anti-coagulant |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1954
|
predictor of unscheduled hospitalization: ACEI/ARB |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1955
|
predictor of unscheduled hospitalization: use of β blocker |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1959
|
predictor of unscheduled hospitalization: low glucose(<84) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1960
|
predictor of unscheduled hospitalization: High AUC PG(>6.165) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1961
|
predictor of unscheduled hospitalization: IGT/DM vs NGT |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1963
|
predictor of mortality: NYHA class |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1966
|
predictor of mortality: Diuretics |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1967
|
predictor of mortality: Anti-coagulant |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1968
|
predictor of mortality: low glucose(<80) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
risk factor |
|
1969
|
FPG |
isolated CHD/non-isolated CHD: TA/UVH/VSD/DORV/TGA/MA/CoA, IAA |
risk factor(Univariate analysis) |
|
1970
|
symptomatic ACHD with lower FPG |
isolated CHD/non-isolated CHD: TA/UVH/VSD/DORV/TGA/MA/CoA, IAA |
risk factor |
|
1971
|
symptomatic ACHD with lower FPG |
isolated CHD/non-isolated CHD: TA/UVH/VSD/DORV/TGA/MA/CoA, IAA |
risk factor |
|
1995
|
serum uric acid(male patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
risk factor |
|
1996
|
serum creatinine(male patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
risk factor |
|
2000
|
CRP (male patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
risk factor |
|
2007
|
CRP (female patients)(mg/dl) |
isolated CHD: VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
risk factor |
|
2012
|
LVID/BSA |
isolated CHD/non-isolated CHD: VSD/PDA/VSD, PDA/CoA/VSD/PDA |
risk factor |
|
2037
|
Relatvie risk for maternal distress 6 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2038
|
mean for maternal distress 18 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2040
|
Relatvie risk for maternal distress 36 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2042
|
relative risk for Child fussiness 6 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2043
|
mean for Child internalizing problems 18 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2044
|
relative risk for Child internalizing problems 36 months |
isolated CHD/non-isolated CHD: non C-CHD/C-CHD/other |
risk factor |
|
2051
|
hippocampi vulume |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2052
|
corpus callosum vulume |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2108
|
correlation between early open-heart surgery and ADHD screening score |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2115
|
cardiac surgery |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2116
|
cyanotic CHD |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2117
|
Endocardial cushion defects(ECD) |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2118
|
Left sided lesions(LSL) |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2119
|
age |
isolated CHD: C-CHD/ECD/LSL/RSL/PDA/VSD/ASD |
risk factor |
|
2130
|
SV and dialysis |
NA: NA |
risk factor(article mentioned) |
|
2131
|
Creatinine>1.5 mg/dL |
NA: NA |
risk factor(article mentioned) |
|
2132
|
Dialysis |
NA: NA |
risk factor(article mentioned) |
|
2133
|
Ventricular assist and dialysis |
NA: NA |
risk factor(article mentioned) |
|
2134
|
Ventricular assist and creatinine>1.5 mg/dL |
NA: NA |
risk factor(article mentioned) |
|
2135
|
SV and reoperation |
NA: NA |
risk factor(article mentioned) |
|
2136
|
Previous operations>2 |
NA: NA |
risk factor(article mentioned) |
|
2137
|
SV and ventricular assist |
NA: NA |
risk factor(article mentioned) |
|
2138
|
SV and dialysis |
NA: NA |
risk factor |
|
2139
|
creatinine>1.5 mg/dL |
NA: NA |
risk factor |
|
2162
|
ADAMTS-13 activity (%) |
isolated CHD: TOF/PA/VSD/UVH |
risk factor |
|
2164
|
preoperative ADAMTS-13 activity of <64.6% |
isolated CHD: TOF/PA/VSD/UVH |
risk factor |
|
2166
|
cardiopulmonary bypass (CPB) |
isolated CHD: TOF/PA/VSD/UVH |
risk factor |
|
2236
|
CHD cases of mother(Indoor renovation) |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2237
|
Indoor renovation--Complex malformation |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2238
|
Indoor renovation--Isolated Cardiac defect |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2239
|
Indoor renovation--Conotruncal defect |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2240
|
Indoor renovation--Anomalous venous return |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2241
|
Indoor renovation--Others Subtype for isolated cardiac defect |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2242
|
Interval between renovation and moving-in(<1 months)--3 months before pregnancy |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2243
|
Interval between renovation and moving-in(<1 months in first trimester) |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/CoA/IAA/other |
risk factor |
|
2246
|
Ischemic time >4 hours |
isolated CHD: TGA/VSD/ASD/TOF/other |
risk factor |
|
2270
|
Average mean pressure pre-induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2271
|
Average diastolic pressure pre-induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2272
|
Difference between systolic pressure pre- and post induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2273
|
Difference between mean pressure pre and post induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2274
|
Difference between diastolic pressure pre- and post induction |
isolated CHD/non-isolated CHD: NA |
risk factor |
|
2275
|
Incidence of level 3–5 adverse event(AE) with different age |
NA: NA |
risk factor |
|
2276
|
Incidence of level 3–5 adverse event(AE) with different Hemodynamic risk factors |
NA: NA |
risk factor |
|
2277
|
Incidence of level 3–5 adverse event(AE) with different Hemodynamic risk factors |
NA: NA |
risk factor |
|
2278
|
Incidence of level 3–5 adverse event(AE) with Procedure type risk group |
NA: NA |
risk factor |
|
2279
|
Incidence of level 3–5 adverse event(AE) with Procedure type risk group |
NA: NA |
risk factor |
|
2280
|
Incidence of level 3–5 adverse event(AE) with Procedure type risk group |
NA: NA |
risk factor |
|
2281
|
Any adverse events: Incidence of AE in different operator years in practice |
NA: NA |
risk factor |
|
2282
|
Incidence of AE(Level 3–5 Adverse Events) in different Operator years in practice |
NA: NA |
risk factor |
|
2283
|
Incidence of AE(Level 3–5 Adverse Events) in different Operator years in practice |
NA: NA |
risk factor |
|
2284
|
Incidence of preventable AE in different Operator years in practice |
NA: NA |
risk factor |
|
2285
|
Incidence of AE in different operator volume (cases/year) |
NA: NA |
risk factor |
|
2292
|
Cardiothoracic ratio--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
risk factor |
|
2293
|
Moderate to severe scoliosis--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
risk factor |
|
2294
|
Diaphragm palsy--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
risk factor |
|
2300
|
Surgical history:Previous thoracotomy--In Relation to Lung Function |
isolated CHD/non-isolated CHD: ASD/VSD/AC/TGA/AVSD/ccTGA/EA/TOF/other |
risk factor |
|
2315
|
6-MWD, m |
isolated CHD: VSD/TA/PDA/TGA |
risk factor |
|
2318
|
cardiac events before pregnancy |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2319
|
New York Heart Association functional class greater than II |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2320
|
oxygen saturation below 90% |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2321
|
left ventricular obstruction (aorta stenosis) |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2322
|
New York Heart Association functional class greater than II |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2323
|
oxygen saturation below 90% |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2324
|
pulmonary arterial hypertension (systolic pressure ≥50 mm Hg) |
isolated CHD: ASD/VSD/PDA/TOF/CVI/MVP |
risk factor |
|
2328
|
Percent of LCHB for patinets with duration of postoperative TCHB ≥7 days |
NA: NA |
risk factor |
|
2343
|
history of >1 thoracotomies |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2344
|
history of atrial arrhythmias |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2345
|
Spirometry suggestive of restrictive lung disease |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2348
|
History of previous surgery |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2349
|
Low heart rate reserve (<70 bpm) |
isolated CHD/non-isolated CHD: CoA/TOF/LVOTO/ASD, VSD, AVSD/SV/D-TGA/ccTGA/EA/PVS |
risk factor |
|
2383
|
Prevalence of first and second-degree relatives |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, ASD, PDA/VSD, PDA, PAH/TOF/HLHS/CoA/PA, VSD, PS/PS, RVOTO/ASD, MRMV, PMT/PA, VSD/SA, SV, CAVC, HLHS/PDA/CAF/VSD, RVOTO, CoA/AS |
risk factor(article mentioned) |
|
2384
|
Prevalence of first-degree relatives |
isolated CHD/non-isolated CHD: ASD/VSD/VSD, ASD, PDA/VSD, PDA, PAH/TOF/HLHS/CoA/PA, VSD, PS/PS, RVOTO/ASD, MRMV, PMT/PA, VSD/SA, SV, CAVC, HLHS/PDA/CAF/VSD, RVOTO, CoA/AS |
risk factor(article mentioned) |
|
2386
|
age |
NA: NA |
risk factor |
|
2387
|
reduced (0.3-0.5) systemic left ventricle ejection fraction(LVEF) |
NA: NA |
risk factor |
|
2392
|
CPB(the duration of cardiopulmonary bypass) |
NA: NA |
risk factor |
|
2410
|
use of cardiopulmonary bypass of one month of age and younger |
NA: NA |
risk factor(article mentioned) |
|
2425
|
risk factor for AKI: age |
NA: NA |
risk factor(article mentioned) |
|
2426
|
risk factor for acute kidney failure: age |
NA: NA |
risk factor(article mentioned) |
|
2428
|
cardiopulmonary bypass time |
NA: NA |
risk factor(article mentioned) |
|
2429
|
Cardiopulmonary bypass of 1 month of age and younger |
NA: NA |
risk factor(article mentioned) |
|
2464
|
Factor related the surgical success rate and complications for ASD: age |
isolated CHD: ASD |
risk factor |
|
2468
|
Factor related the surgical success rate and comlications for VSD: distance from VSD to AV |
isolated CHD: VSD |
risk factor |
|
2469
|
Factor related the surgical success rate and comlications for VSD: pulmonary arterial hypertension(PAH) |
isolated CHD: VSD |
risk factor |
|
2471
|
Risk factor related the occurrence of complications for VSD: device size |
isolated CHD: VSD |
risk factor |
|
2473
|
Risk factor related the occurrence of complications for PBPV: PS degree |
isolated CHD: PS |
risk factor |
|
2475
|
risk factors for all the events (early and late death): urgency status |
isolated CHD/non-isolated CHD: UVH/TA/DILV, PA/DILV, PS/DILV/UVH, TGA/HLHS/DOLV/UAVC/PA, IVS/TOF/PA, VSD/TGA/TGA/AVC/EA/SD/MD/AD, CoA/CoA, VSD/TAPVR/CACA/TOF, AVC/MAD |
risk factor |
|
2476
|
risk factors for all the events (early and late death): preoperative mechanical ventilation |
isolated CHD/non-isolated CHD: UVH/TA/DILV, PA/DILV, PS/DILV/UVH, TGA/HLHS/DOLV/UAVC/PA, IVS/TOF/PA, VSD/TGA/TGA/AVC/EA/SD/MD/AD, CoA/CoA, VSD/TAPVR/CACA/TOF, AVC/MAD |
risk factor |
|
2510
|
BMI (3 categories) |
NA: NA |
risk factor |
|
2513
|
goiter |
NA: NA |
risk factor |
|
2514
|
BMI 3 catergories (reference=BMI>25) |
NA: NA |
risk factor |
|
2526
|
correlation between BMI and higher AIT risk |
NA: NA |
risk factor |
|
2528
|
Risk factor of AIT: BMI<21 (ref=BMI>25) |
NA: NA |
risk factor |
|
2529
|
Risk factor of AIT: goiter |
NA: NA |
risk factor |
|
2542
|
association between double BNP level with heart failure |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2543
|
correlation between BNP with heart failure in single ventricle group |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2544
|
correlation between BNP with heart failure in all patients with Stage II |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2545
|
correlation between double NT-proBNP with heart failure |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2546
|
correlation between double NT-proBNP with heart failure in single ventricle group |
isolated CHD/non-isolated CHD: HLHS/MA/MS/AA/MS/AS/RDACD/DORV/IAA, VSD, SLV/AS, PS, LV/AS, L-TGA, PS, SLV/TA/PA, IVS/DILV/D-TGA, MV, RV/PS, RV |
risk factor |
|
2553
|
correlation between exceeding CTR increasing and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2554
|
correlation between mild CTR increasing and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2555
|
correlation between NYHA class and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2556
|
correlation between NYHA class and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2557
|
correlation between NYHA class and the risk of mortality |
isolated CHD/non-isolated CHD: PDA/AC/VSD/AS, TGA/TGA/ASD/ccTGA/ASD/TOF/EIS/EA |
risk factor |
|
2585
|
association of plasma VWF:Ag with the risk of death adjusted for : gender |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2586
|
association of plasma VWF:Ag with the risk of death adjusted for : clinical presentation |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2587
|
association of plasma VWF:Ag with the risk of death adjusted for : functional class |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2588
|
association of plasma VWF:Ag with the risk of death adjusted for : resting SpO2 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2589
|
association of plasma VWF:Ag with the risk of death adjusted for : 6-min walk SpO2 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2590
|
association of plasma VWF:Ag with the risk of death adjusted for : 6-min walk distance |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2591
|
association of plasma VWF:Ag with the risk of death adjusted for : Hematocrit |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2592
|
association of plasma VWF:Ag with the risk of death adjusted for : PAH advanced therapy |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2593
|
association of plasma VWF:Ag with the risk of death adjusted for : Duration of treatment |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2594
|
association of plasma VWF:Ag with the risk of death adjusted for : PAP systolic |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2595
|
association of plasma VWF:Ag with the risk of death adjusted for : statin |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2596
|
association of plasma VWF:Ag with the risk of death adjusted for : age |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2597
|
association of plasma VWF:Ag with the risk of death adjusted for : gender |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2598
|
association of plasma VWF:Ag with the risk of death adjusted for : clinical presentation |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2599
|
association of plasma VWF:Ag with the risk of death adjusted for : functional class |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2600
|
association of plasma VWF:Ag with the risk of death adjusted for : resting SpO2 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2601
|
association of plasma VWF:Ag with the risk of death adjusted for : 6-min walk SpO2 |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2602
|
association of plasma VWF:Ag with the risk of death adjusted for : 6-min walk distance |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2603
|
association of plasma VWF:Ag with the risk of death adjusted for : Hematocrit |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2604
|
association of plasma VWF:Ag with the risk of death adjusted for : PAH advanced therapy |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2605
|
association of plasma VWF:Ag with the risk of death adjusted for : Duration of treatment |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2606
|
association of plasma VWF:Ag with the risk of death adjusted for : PAP systolic |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2607
|
association of plasma VWF:Ag with the risk of death adjusted for : statin |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
risk factor |
|
2633
|
age < 1 month |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2634
|
gender |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2635
|
use of cardiopulmonary bypass |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2637
|
Risk Adjusted classification for Congenital Heart Surgery, version 1, > 3 |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2638
|
Initial lactate (mmol/L) |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2639
|
Dopamine |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2640
|
Epinephrine |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2641
|
Milrinone |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2643
|
age < 1 month |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2645
|
use of cardiopulmonary bypass |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2647
|
Risk Adjusted classification for Congenital Heart Surgery, version 1, > 3 |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2649
|
Dopamine |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2650
|
Epinephrine |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2651
|
Milrinone |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2652
|
age < 1 month |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2653
|
use of cardiopulmonary bypass |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2655
|
Milrinone |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
risk factor |
|
2662
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Body surface area |
NA: NA |
risk factor |
|
2667
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Indexed pulmonary blood flow |
NA: NA |
risk factor |
|
2668
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Stroke volume |
NA: NA |
risk factor |
|
2670
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Pulmonary artery ejection time |
NA: NA |
risk factor |
|
2672
|
association between RV and pulmonary dynamics with the distance walked in 6 minutes: Cardiac index |
NA: NA |
risk factor |
|
2727
|
≤ 2.5 kg at operation |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2728
|
Gestational age < 37 wks |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2729
|
Re-operation within admission |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2737
|
logistic regression analysis and risk of mortality: Transformed age (days) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2739
|
logistic regression analysis and risk of mortality: RACHS score |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2741
|
logistic regression analysis and risk of mortality: RACHS score(neonates≤30 days) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2742
|
logistic regression analysis and risk of mortality: RACHS score(Neonates, operations requiring CPB) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
risk factor |
|
2753
|
PA/VSD(risk factors associated with redo PVR) |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
risk factor |
|
2754
|
Stentless(risk factors associated with redo PVR) |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
risk factor |
|
2766
|
LDL-cholesterol(cut off>3.3mmol/l)(association between maternal lipids and total homocysteine and CHD risk) |
NA: NA |
risk factor |
|
2767
|
Total/HDL-cholesterol(cut off>3.5 mmol/l)(association between maternal lipids and total homocysteine and CHD risk) |
NA: NA |
risk factor |
|
2768
|
Apolipoprotein B(cut off >85.0 mg/dl)(association between maternal lipids and total homocysteine and CHD risk) |
NA: NA |
risk factor |
|
2769
|
Apolipoprotein B/A-1 (cut off >0.6)(association between maternal lipids and total homocysteine and CHD risk) |
NA: NA |
risk factor |
|
2770
|
Total cholesterol (association between maternal lipids and total homocysteine as continuous variables and CHD risk) |
NA: NA |
risk factor |
|
2771
|
LDL-cholesterol (association between maternal lipids and total homocysteine as continuous variables and CHD risk) |
NA: NA |
risk factor |
|
2772
|
Apolipoprotein B (association between maternal lipids and total homocysteine as continuous variables and CHD risk) |
NA: NA |
risk factor |
|
2773
|
Apolipoprotein B/A-1 (association between maternal lipids and total homocysteine as continuous variables and CHD risk) |
NA: NA |
risk factor |
|
2784
|
Predictor indications of prolonger PICU) stay: Age ≤6 months |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2785
|
Predictor indications of prolonger PICU) stay: RACHS-1 category |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor(Univariate analysis) |
|
2786
|
Predictor indications of prolonger PICU) stay: CPB time ≥78 min |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2787
|
Predictor indications of prolonger PICU) stay: NT-BNP preoperative ≥3.4 log |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2788
|
Predictor indications of prolonger PICU) stay: NT-BNP-peak ≥4.22 log |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2789
|
Predictor indications of prolonger PICU) stay: Troponine postoperative ≥4.4ng/ml |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2790
|
Predictor indications of prolonger PICU) stay: Postoperative lactate ≥3.4 mmolyl |
isolated CHD/non-isolated CHD: AVSD/VSD/ASD/PAPVC/TAPVC/MR/PR/AR/AP window/TGA/DORV/TOF/CoA/TA, IAA/SPS/AS/PA/PA, VSD/SV/TGA, VSD |
risk factor |
|
2840
|
relationship between fibrosis index and EDVi (end-diastolic volume index ) |
NA: NA |
risk factor(article mentioned) |
|
2841
|
relationship between fibrosis index and EF (ventricular ejection fraction) |
NA: NA |
risk factor(article mentioned) |
|
2845
|
age<2 years and relation with the need for reintervention |
isolated CHD/non-isolated CHD: TOF/TA/D-TGA/ASD/DORV/SVAS, BPAS/isolated BPAS |
risk factor(article mentioned) |
|
2846
|
diagnosis of TOF and relation with reintervention |
isolated CHD/non-isolated CHD: TOF/TA/D-TGA/ASD/DORV/SVAS, BPAS/isolated BPAS |
risk factor(article mentioned) |
|
2847
|
diagnosis of truncus arteriosus and relation with reintervention |
isolated CHD/non-isolated CHD: TOF/TA/D-TGA/ASD/DORV/SVAS, BPAS/isolated BPAS |
risk factor(article mentioned) |
|
2873
|
Postoperative TnT (ug l-1) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
risk factor |
|
2875
|
Temperature (℃) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
risk factor |
|
2877
|
Baseline characteristics: Twin pregnancy (%) |
NA: NA |
risk factor(article mentioned) |
|
2878
|
Residual lesions at conception: Pulmonary regurgitation ≥ grade II (%) |
NA: NA |
risk factor(article mentioned) |
|
2879
|
Residual lesions at conception: Branch pulmonary artery stenosis or occlusion (%) |
NA: NA |
risk factor(article mentioned) |
|
2895
|
balloon atrial septostomy (BAS) |
isolated CHD: TGA/SV |
risk factor |
|
2896
|
balloon atrial septostomy (BAS) |
isolated CHD: TGA/SV |
risk factor |
|
2954
|
BNP concentrations |
isolated CHD: TOF/SV/HRV |
risk factor |
|
2955
|
ANP concentrations |
isolated CHD: TOF/SV/HRV |
risk factor |
|
2963
|
higher plasma creatinine(mg/dL) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2964
|
receiving diuretics(%) |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2966
|
prevalence of hyponatraemia in NYHA class |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2968
|
five-year death rate in hyponatraemia patients |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2969
|
relation between hyponatraemia and death |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
risk factor |
|
2972
|
preoperative cyanosis |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
risk factor |
|
2973
|
reoperation |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
risk factor |
|
2974
|
length of ICU stay |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
risk factor |
|
3004
|
Hematocrit |
NA: NA |
risk factor |
|
3005
|
Systolic blood pressure(SBP) at CICU admission |
NA: NA |
risk factor |
|
3006
|
Birth weight |
NA: NA |
risk factor |
|
3007
|
Intubation(after hemodilution on cardiopulmonary bypass) |
NA: NA |
risk factor |
|
3008
|
Systolic blood pressure(SBP) at CICU admission |
NA: NA |
risk factor |
|
3090
|
Older recipient age |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3091
|
Previous Fontan operation |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3092
|
Longer ischemic time |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3093
|
Interaction of donor age and ischemic time |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3094
|
Higher pre-Tx mean RAP (only in patients without previous Fontan) |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3095
|
Younger recipient age |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3096
|
Higher systolic transpulmonary gradient |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3097
|
cytomegalovirus+ donor, cytomegalovirus- recipient |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3098
|
Previous classical Glenn operation |
isolated CHD/non-isolated CHD: VSD/ASD/TGA/AVC/other |
risk factor |
|
3111
|
correlation between marital status (single) and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
risk factor |
|
3112
|
correlation between nulliparity and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
risk factor |
|
3114
|
correlation between somking history and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
risk factor |
|
3115
|
correlation between nulliparity and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
risk factor |
|
3141
|
Neonatal asphyxia or hypoxia (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3142
|
maternal upper respiratory infection (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3143
|
number of previous pregnancies |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3144
|
maternal infection (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3145
|
maternal B-mode ultrasound examination (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3146
|
maternal mental stress |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
risk factor |
|
3147
|
changes in respiratory rates/rhythms |
NA: NA |
risk factor |
|
3148
|
adventitious breath sounds |
NA: NA |
risk factor |
|
3149
|
sputum production |
NA: NA |
risk factor |
|
3151
|
having two or more indicators |
NA: NA |
risk factor |
|
3152
|
having two to four indicators |
NA: NA |
risk factor |
|
3153
|
CVL duration over 3 days |
isolated CHD: VSD/ASD/TOF/TGA |
risk factor |
|
3154
|
age < 28 days |
isolated CHD: VSD/ASD/TOF/TGA |
risk factor |
|
3176
|
combined with atrial fibrillation (AF) type of tachyarrhythmias |
isolated CHD/non-isolated CHD: TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
risk factor |
|
3182
|
overall mortality rates |
NA: NA |
risk factor |
|
3183
|
mortality rates stratified by gender (girls) |
NA: NA |
risk factor |
|
3184
|
mortality rates stratified by age (more than 1 year old) |
NA: NA |
risk factor (crude OR) |
|
3185
|
mortality rates stratified by body weight (more than 5kg) |
NA: NA |
risk factor |
|
3186
|
mortality rates stratified by RACHS-1 (1 and 2) |
NA: NA |
risk factor |
|
3187
|
mortality rates stratified by CPB time (more than 60min) |
NA: NA |
risk factor |
|
3188
|
mortality rates stratified by Cyanosis (no-cyanosis) |
NA: NA |
risk factor |
|
3192
|
risk of IE with foreign material implantation undergoing cardiac catheter interventions |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
risk factor |
|
3193
|
risk of IE with pacemaker implantation |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
risk factor |
|
3194
|
risk of IE with pacemaker implantation |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
risk factor |
|
3195
|
risk of IE with pacemaker implantation |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
risk factor |
|
3211
|
correlation between cumulative mortality and GFR reduction |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3212
|
correlation between cumulative mortality and GFR reduction |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3213
|
correlation between 6-year cumulative mortality and GFR reduction |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3214
|
correlation between moderate to severe impairment of GFR and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3215
|
correlation between moderate to severe impairment of GFR and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3216
|
correlation between NYHA class >2 and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3217
|
correlation between systemic ventricular dysfunction and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3218
|
correlation between previous palliative surgery and mortality |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/CoA/TOF/ccTGA/EA/ES/PA/other |
risk factor |
|
3231
|
association between Apgar score and CVP score after controlling for variables |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
risk factor |
|
3232
|
association between mortality and CVP score after controlling for variables |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
risk factor |
|
3233
|
association between mortality and hydrops (CVP category of ultrasound marker) |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
risk factor |
|
3234
|
association between mortality and cardiomegaly with a heart to chest area ratio > 0.5 (CVP category of ultrasound marker) |
isolated CHD/non-isolated CHD: HLHS/HRHS/TA/DILV/DORV, MA/SILV/AA/AS, PS/AVC, PS/TOF/TGA/DORV/AVC/VSD/SASD/APVR/EA/PA/TVD/CoA/AS/IAA/RAI |
risk factor |
|
3242
|
age ( < 360 days) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
risk factor |
|
3245
|
CPB duration > 90 min |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
risk factor |
|
3246
|
risk of postoperative JET |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
risk factor |
|
3247
|
CK-MB ( > 100μg/mL) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
risk factor |
|
3251
|
age < 1 year |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3252
|
Cyanotic CHD |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3253
|
previous surgery for CHD |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3254
|
Perioperative IE |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3255
|
S.aureus as causative organism |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3256
|
Nosocomial IE |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3257
|
vegetation size >=15mm |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3258
|
vegetation size >=20mm |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3259
|
presence of HF |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3260
|
vegetation size >=20mm |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3261
|
age < 1 year |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3262
|
presence of HF |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3263
|
S.aureus as causative organism |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
risk factor |
|
3266
|
RACHS-1 score=4-6 |
NA: NA |
risk factor |
|
3267
|
CPB time(min)>=90 |
NA: NA |
risk factor |
|
3299
|
Living independently from parents |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3300
|
American Heart Association II as compared to III |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3301
|
Symptoms on presentation |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3302
|
Additional diagnosis made |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3303
|
Lapse of medical care |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3304
|
Symptoms on presentation |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3305
|
Additional diagnosis made |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3306
|
Additional diagnosis made |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3307
|
American Heart Association II as compared to III |
isolated CHD/non-isolated CHD: DOV/ES/SV/PA/TC/TA/LRAI/AVSD/CoA/EA/TOF/PI/PS/SVA/SAS/ASD/PDA |
risk factor |
|
3309
|
age (months) (mean±SD) |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3310
|
Body weight (mean±SD) |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3311
|
Aristotle Basic Score |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3312
|
CPB time |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3313
|
Aortic crosslamp time |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3314
|
IPPV(intermittent positive pressure ventilation) time (hour) |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3315
|
ICU stay (days) |
isolated CHD/non-isolated CHD: VSD/CAVSD/TOF/TGA, VSD/TGA, IVS/SV, DILV/SV, TA/TAPVC/AOR/ASD/VSD/PAVSD/PA, VSD/AOS/SV/VSD, CoA/TGA, VSD, LVOTO/ccTGA, VSD/ccTGA, VSD, LVOTO/ALCAPA/RVOTO, PS, AOS |
risk factor (article mentioned) |
|
3389
|
NYHA functional class |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3390
|
Antiarrhythmic therapy (excl.digoxin) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3391
|
Antiarrhythmic therapy (incl.digoxin) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3392
|
Amiodarone therapy |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3393
|
Digoxin therapy |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3395
|
Antiarrhythmic therapy (incl.digoxin) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3396
|
NYHA functional class |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3398
|
Amiodarone therapy |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3399
|
NYHA functional class |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
risk factor |
|
3401
|
smoking behavior |
NA: NA |
risk factor (article mentioned) |
|
3402
|
Participation in sports |
NA: NA |
risk factor (article mentioned) |
|
3403
|
blood pressure (mmHg) |
NA: NA |
risk factor (article mentioned) |
|
3404
|
BMI (kg/m2) |
NA: NA |
risk factor (article mentioned) |
|
3405
|
no-smoking behavior |
NA: NA |
risk factor (article mentioned) |
|
3406
|
Participation in sports |
NA: NA |
risk factor (article mentioned) |
|
3407
|
high blood pressure |
NA: NA |
risk factor (article mentioned) |
|
3408
|
BMI (kg/m2) overweighted |
NA: NA |
risk factor (article mentioned) |
|
3409
|
Adolescent cohort |
NA: NA |
risk factor |
|
3411
|
Pediatric cardiac visits at least once per year |
NA: NA |
risk factor |
|
3412
|
Diagnosis with higher risk of early death |
NA: NA |
risk factor |
|
3413
|
Some activity restrictions |
NA: NA |
risk factor |
|
3414
|
physical health limitaions |
NA: NA |
risk factor |
|
3415
|
mental health problems |
NA: NA |
risk factor |
|
3416
|
role limitations because of physical and/or emotional problems |
NA: NA |
risk factor |
|
3417
|
fair or poor overall health status |
NA: NA |
risk factor |
|
3418
|
more pessimistic view of life and health |
NA: NA |
risk factor |
|
3419
|
increasing perceptions of risk for CHD complications |
NA: NA |
risk factor |
|
3420
|
increasing perceptions of risk from not attending follow-up appointments with cardiologist |
NA: NA |
risk factor |
|
3421
|
Diagnosis with higher risk of early death |
NA: NA |
risk factor |
|
3422
|
fair or poor overall health status |
NA: NA |
risk factor |
|
3423
|
increasing perception of risk for CHD complications |
NA: NA |
risk factor |
|
3443
|
Malnutrition |
NA: NA |
risk factor |
|
3445
|
TISS score: 7 days after admission |
NA: NA |
risk factor (article mentioned) |
|
3447
|
parenternal nutrition |
NA: NA |
risk factor |
|
3448
|
Candida colonization |
NA: NA |
risk factor |
|
3449
|
antibiotic treatment (any) |
NA: NA |
risk factor |
|
3450
|
antibiotic treatment (third-generation cephalosporins) |
NA: NA |
risk factor |
|
3451
|
antibiotic treatment (Glycopeptides) |
NA: NA |
risk factor |
|
3452
|
antibiotic treatment (Carbapenems) |
NA: NA |
risk factor |
|
3453
|
antibiotic treatment (Aminoglycosides) |
NA: NA |
risk factor |
|
3455
|
association between receipt of antibiotic treatment for more than 5 days and the acquistion of candidemia |
NA: NA |
risk factor |
|
3457
|
correlation between antibiotic treatment administered for more than 5 days and the risk of acquiring candidemia |
NA: NA |
risk factor |
|
3468
|
correlation between heart failure and patients with pacemaker |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
risk factor |
|
3469
|
correlation between chronotropic incompetence and patients with pacemaker |
isolated CHD/non-isolated CHD: TOF/D-TGA/SV/LTRS/AVD, PVD, CoA/other |
risk factor |
|
3491
|
risk for heart failure in patients with TOF |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3492
|
risk for heart failure in patients with TGA (atrial diversion procedure |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3493
|
risk for heart failure in patients with Single ventricle |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3494
|
risk for heart failure in patients with miscellaneous |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3495
|
risk for heart failure in patients with transanular patch |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3496
|
risk for heart failure in patients with pulmonary valve replacement |
isolated CHD/non-isolated CHD: LRS/TOF/D-TGA/SV/AVD, PVD/AC/other |
risk factor |
|
3499
|
Age (yrs) |
isolated CHD/non-isolated CHD: VSD/TOF/ASD/PDA/SS/TA/PA, VSD/TAPVC/CoA/CAVC/PA, IVS/DORV/D-TGA/TA/other |
risk factor (article mentioned) |
|
3510
|
baseline NYHA class>=2 |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3512
|
prior history of heart failure |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3513
|
smoking history |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3514
|
pulmonary regurgitation |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3515
|
severe pulmonary regurgitation |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3516
|
depressed subpulmonary ventricular EF |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3517
|
depressed morphological right ventricular EF |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3518
|
severe pulmonary regurgitation or depressed subpulmonary ventricular EF |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3519
|
smoking history |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3520
|
oxygen saturation per 1% decrease |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3521
|
oxygen saturation per 1% decrease |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3522
|
smoking history |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3524
|
subaortic ventricular outflow tract gradient (gradient >30mmHg) |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3525
|
symptomatic arrhythmia during pregnancy |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3526
|
subaortic ventricular outflow tract gradient (gradient >30mmHg) |
isolated CHD/non-isolated CHD: ASD/VSD/PS/PA, VSD/AS/TA/TOF/TGA/D-TGA, VSD/SV/EA |
risk factor |
|
3528
|
cardiovascular compromise |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3529
|
>=1 end organ dysfunctions |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3530
|
admit age (days) |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3531
|
CHD type: SV versus PA |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3532
|
cardiovascular compromise |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3533
|
CHD type: SV versus PA |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
risk factor |
|
3537
|
age (years) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3538
|
inotropic score (μg/kg/min) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3539
|
ischemic time (min) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3540
|
CBP time (min) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3541
|
Clamp time (min) |
isolated CHD/non-isolated CHD: VSD/ASD/TOF/AV/AVC/AS/RVOTO/CoA/PDA/other |
risk factor(article mentioned) |
|
3671
|
Duration of TPN (total parenteral nutrition), d (mean ± SD) |
non-isolated CHD: TGV, PDA, PFO, VSD, CoA/PDA, TGV, VSD, DORV/CoA, LVH/RVH, SV, TGV, CoA, VSD/HLHS, AA, PDA/TOF, TAPVR, ASD |
risk factor (article mentioned) |
|
3672
|
Duration of antibiotics, d (mean ± SD) |
non-isolated CHD: TGV, PDA, PFO, VSD, CoA/PDA, TGV, VSD, DORV/CoA, LVH/RVH, SV, TGV, CoA, VSD/HLHS, AA, PDA/TOF, TAPVR, ASD |
risk factor (article mentioned) |
|
3673
|
Bypass time (min) |
non-isolated CHD: TGV, PDA, PFO, VSD, CoA/PDA, TGV, VSD, DORV/CoA, LVH/RVH, SV, TGV, CoA, VSD/HLHS, AA, PDA/TOF, TAPVR, ASD |
risk factor (article mentioned) |
|
3674
|
Clinical signs and presence of thrombus |
non-isolated CHD: TGV, PDA, PFO, VSD, CoA/PDA, TGV, VSD, DORV/CoA, LVH/RVH, SV, TGV, CoA, VSD/HLHS, AA, PDA/TOF, TAPVR, ASD |
risk factor (article mentioned) |
|
3691
|
female patients |
isolated CHD/non-isolated CHD: LTRS/TOF/TOF, PA/VSD, PS/TGA/APVR/LVOTO |
risk factor (article mentioned) |
|
3693
|
warfarin |
isolated CHD/non-isolated CHD: LTRS/TOF/TOF, PA/VSD, PS/TGA/APVR/LVOTO |
risk factor (article mentioned) |
|
3706
|
factors affecting late mortality: gender |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3707
|
factors affecting late mortality: age at conduit operation |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3708
|
factors affecting late mortality: age at conduit operation |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3709
|
factors affecting late mortality: diagnosis of TGA |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3710
|
factors affecting late mortality: diagnosis of TA |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3711
|
factors affecting late mortality: diagnosis of corrected TGA |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3712
|
factors affecting late mortality: diagnosis of univentricular heart |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3713
|
pulmonary ventricle/systemic ventricle ratio |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3716
|
risk factors for conduit failure: conduit size |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3717
|
risk factors for conduit failure: conduit size |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3718
|
risk factors for conduit failure: conduit size |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3719
|
risk factors for Conduit failure: diagnosis of TGA |
isolated CHD/non-isolated CHD: TGA/PA, TOF |
risk factor (article mentioned) |
|
3720
|
risk factors for conduit failure: type of prosthsis: homograft |
isolated CHD/non-isolated CHD: TGA, VSD/TGA, PS, VSD/TGA, PA/TGA, PS/TA, PA/PA, VSD/PA, IVS/DORV, VSD/DORV, PS/DORV, VSD, PS/TOF/TGA/TA/UVH/other |
risk factor (article mentioned) |
|
3721
|
Mean age at listing (years) |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
risk factor (article mentioned) |
|
3722
|
Median age at listing (years) |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
risk factor (article mentioned) |
|
3724
|
Onset of heart failure to listing (months) |
isolated CHD/non-isolated CHD: PA, IVS/TA/TA/TS/HLHS/PA, VSD/TC/LSOD/ASD/CACA/TA/ECD/TOF/other |
risk factor (article mentioned) |
|
3739
|
overall mean vessel diameter |
isolated CHD: TOF/PA/CBPS/TR |
risk factor (article mentioned) |
|
3764
|
Functionally univentricular cardiac anomaly |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3765
|
Univentricular anomaly with arch obstruction |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3766
|
HLHS |
isolated CHD: HLHS |
risk factor |
|
3767
|
TA/AP W |
non-isolated CHD: TA/AP window |
risk factor |
|
3769
|
Prematurity(<36 weeks) |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3770
|
neonatal clinical variables: Episode of low cardiac output or shock |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3771
|
neonatal clinical variables: Highest prostaglandin dose 0.05 g/kg/min |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3772
|
risk of death in different stage number of NEC patients |
isolated CHD/non-isolated CHD: TOF/CoA, IAA/TA, AP window/TGA/SV/HLHS/SV, AAO/PS/TOF, PA/APV |
risk factor |
|
3831
|
nonurban location |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3832
|
nonurban location |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3833
|
lesions: valvular aortic stenosis |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3834
|
lesions: tetralogy of Fallot |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3835
|
insurance |
isolated CHD: AS/ASD/TOF |
risk factor (article mentioned) |
|
3839
|
preoperative pulmonary hypertension |
isolated CHD: TAPVC/TGA/VSD/HLHS/TA/AVC |
risk factor |
|
3840
|
absence of mixed venous saturation monitoring |
isolated CHD: TAPVC/TGA/VSD/HLHS/TA/AVC |
risk factor(article mentioned) |
|
3841
|
absence of prophylactic alpha-blockade |
isolated CHD: TAPVC/TGA/VSD/HLHS/TA/AVC |
risk factor(article mentioned) |
|
3842
|
postoperative pulmonary hypertension |
isolated CHD: TAPVC/TGA/VSD/HLHS/TA/AVC |
risk factor |
|
3921
|
Immunocompromised |
isolated CHD/non-isolated CHD: TA/TOF/PA, IVS/D-TGA/PS/D-TGA, DORV |
risk factor |
|
3943
|
association with sex and dental health behaviours(brush teeth 2 times/day) |
NA: NA |
risk factor |
|
3944
|
association with education status and dental health behaviours(brush teeth 2 times/day) |
NA: NA |
risk factor |
|
3948
|
association with sports participation with married status |
NA: NA |
risk factor |
|
3949
|
association between sports participation with education |
NA: NA |
risk factor |
|
3950
|
association between sports participation with employment |
NA: NA |
risk factor |
|
3953
|
<37 week gestation |
isolated CHD: SV dd-SBF/BiV dd-SBF/D-TGA/BiV dd-PBF/SV dd-PBF/SV/TA/other |
risk factor |
|
3954
|
Feeds>100 ml/kg/d |
isolated CHD: SV dd-SBF/BiV dd-SBF/D-TGA/BiV dd-PBF/SV dd-PBF/SV/TA/other |
risk factor |
|
3956
|
cardiac lesion of BiV dd-PBF(ductal-dependent pulmonary perfusion) |
isolated CHD: BiV dd-PBF |
risk factor |
|
3973
|
relative average miRNA-208 expression in children with oxygen saturation below 90% |
NA: VSD, ASD/AVC/TGA/TOF/CoA/RV to PAC |
risk factor |
|
3996
|
maternal upper respiratory tract infection/ influenza during early pregnancy with CHD in offspring |
isolated CHD/non-isolated CHD: NA/VSD/TOF |
risk factor |
|
3997
|
maternal upper respiratory tract infection/ influenza during early pregnancy with simple CHD in offspring |
isolated CHD: NA |
risk factor |
|
3998
|
maternal upper respiratory tract infection/ influenza during early pregnancy with VSD in offspring |
isolated CHD: VSD |
risk factor |
|
3999
|
\maternal upper respiratory tract infection/ influenza during early pregnancy with complex CHD in offspring |
non-isolated CHD: NA |
risk factor |
|
4000
|
maternal upper respiratory tract infection/ influenza during early pregnancy with TOF in offspring |
isolated CHD: TOF |
risk factor |
|
4019
|
NLRP3(nucleotide-binding oligomerization domain-like (NOD)-like receptor protein 3) |
NA: NA |
risk factor |
|
4020
|
HMGB1(high-mobility group box 1) |
NA: NA |
risk factor |
|
4036
|
Modified Ross score |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
risk factor |
|
4038
|
OER(Oxygen extraction rate) |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
risk factor |
|
4060
|
assocciated factors with ASD: women |
isolated CHD: ASD |
risk factor |
|
4061
|
assocciated factors with ASD: age(10-19 years) |
isolated CHD: ASD |
risk factor |
|
4062
|
assocciated factors with ASD: age(20-39 years) |
isolated CHD: ASD |
risk factor |
|
4063
|
assocciated factors with ASD: age(>40 years) |
isolated CHD: ASD |
risk factor |
|
4068
|
obese |
NA: NA |
risk factor |
|
4069
|
overweight |
NA: NA |
risk factor |
|
4073
|
Post-operative infection |
NA: NA |
risk factor |
|
4079
|
BMI(<5th percentile)(infants) |
NA: NA |
risk factor |
|
4081
|
STS(Society of Thoracic Surgeons) risk grade(infants) |
NA: NA |
risk factor |
|
4082
|
Delayed sternal closure(infants) |
NA: NA |
risk factor |
|
4083
|
serum creatinine(>cut off value)(infants) |
NA: NA |
risk factor |
|
4085
|
Neutrophil count(>cut off value)(infants) |
NA: NA |
risk factor |
|
4086
|
Lymphocytes/WBC(<cut off value)infants) |
NA: NA |
risk factor |
|
4089
|
Neutrophils/WBC(>cut off value)(infants) |
NA: NA |
risk factor |
|
4092
|
history of cardiac surgery(children) |
NA: NA |
risk factor |
|
4093
|
BMI(<5th percentile)(children) |
NA: NA |
risk factor |
|
4094
|
STS(Society of Thoracic Surgeons) risk grade(children) |
NA: NA |
risk factor |
|
4095
|
Delayed sternal closure(children) |
NA: NA |
risk factor |
|
4097
|
Lymphocyte count(<cut off value)(children) |
NA: NA |
risk factor |
|
4099
|
Lymphocytes/WBC(<cut off value)(children) |
NA: NA |
risk factor |
|
4101
|
Neutrophil count(>cut off value)(children) |
NA: NA |
risk factor |
|
4102
|
Neutrophils/WBC(>cut off value)(children) |
NA: NA |
risk factor |
|
4103
|
ALT(>cut off value)(children) |
NA: NA |
risk factor |
|
4104
|
AST(>cut off value)(children) |
NA: NA |
risk factor |
|
4105
|
prevalence of CHD in different sex |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
risk factor |
|
4106
|
prevalence of CHD in different maternal age |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
risk factor |
|
4107
|
prevalence of CHD in different gestation age |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
risk factor |
|
4108
|
prevalence of CHD in different birthweight(g) |
isolated CHD: ASD/VSD/PDA/BAV/TOF/PS/AVSD/TGA/EA/other |
risk factor |
|
4116
|
maternal education level(low:compulsory only) |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4117
|
Pregestational Diabetes |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4118
|
Poor diet(low fruit & vegetable) |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4120
|
Fizzy or high energy every day |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4121
|
Pregnancy-related stress |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4122
|
Multiple stress events >3 |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4123
|
Self-reported maternal clotting disorder |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4124
|
Prescriptions in the first three months of pregnancy of the anti-clotting medication enoxaparin |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4125
|
Prescriptions in the first three months of pregnancy of the anti-clotting medication aspirin |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4126
|
Paternal raised blood pressure |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4127
|
Vaginal infection/thrush |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
risk factor |
|
4129
|
BMI(<5th percentile) |
NA: NA |
risk factor |
|
4131
|
aortic shunt(left-to-right) |
NA: NA |
risk factor |
|
4132
|
aortic shunt(right-to-left) |
NA: NA |
risk factor |
|
4133
|
aortic shunt(Bi-directional) |
NA: NA |
risk factor |
|
4135
|
atrial shunt(left-to-right) |
NA: NA |
risk factor |
|
4136
|
atrial shunt(right-to-left) |
NA: NA |
risk factor |
|
4137
|
atrial shunt(Bi-directional) |
NA: NA |
risk factor |
|
4141
|
ventricular level shunt(Bi-directional) |
NA: NA |
risk factor |
|
4142
|
Aortic Insufficiency(AI)(minimal) |
NA: NA |
risk factor |
|
4144
|
Tricuspid Regurgitation(TR)(minimal) |
NA: NA |
risk factor |
|
4145
|
with mitral insufficiency(MI) |
NA: NA |
risk factor |
|
4146
|
History of cardiac surgery |
NA: NA |
risk factor |
|
4147
|
RACHS-1 risk grade 1 |
NA: NA |
risk factor |
|
4150
|
selective extracorporeal surgery |
NA: NA |
risk factor |
|
4151
|
emergency extracorporeal surgery |
NA: NA |
risk factor |
|
4153
|
circulating temperature(mild hypothemia) |
NA: NA |
risk factor |
|
4154
|
circulating temperature(deep hypothemia) |
NA: NA |
risk factor |
|
4155
|
circulating temperature(middle and low temperature) |
NA: NA |
risk factor |
|
4156
|
circulation method(low folw cycle) |
NA: NA |
risk factor |
|
4157
|
circulation method(cerebral perfusion) |
NA: NA |
risk factor |
|
4158
|
circulation method(Circulatory arrest) |
NA: NA |
risk factor |
|
4162
|
myocardial preservation(Cold blood cardioplegia (4:1)) |
NA: NA |
risk factor |
|
4163
|
with residual shunt |
NA: NA |
risk factor |
|
4164
|
with LVOTO |
NA: NA |
risk factor |
|
4165
|
with RVOTO |
NA: NA |
risk factor |
|
4166
|
postoperative rhythm of the heart(III° AVB) |
NA: NA |
risk factor |
|
4167
|
postoperative rhythm of the heart(II° AVB) |
NA: NA |
risk factor |
|
4172
|
Relative mortality risk after pulmonary valve replacement(age brackets of 40–45) |
isolated CHD: TOF |
risk factor |
|
4182
|
risk of PTB |
isolated CHD: NA |
risk factor |
|
4183
|
risk of SGA |
isolated CHD: NA |
risk factor |
|
4186
|
risk of preterm birth of different age(35-39 years) |
isolated CHD: NA |
risk factor |
|
4187
|
risk of preterm birth of different age(40-44 years) |
isolated CHD: NA |
risk factor |
|
4190
|
risk of preterm birth to SGA of different age(35-39 years) |
isolated CHD: NA |
risk factor |
|
4191
|
risk of preterm birth to SGA of different age(40-44 years) |
isolated CHD: NA |
risk factor |
|
4192
|
higher risk of PTB at maternal age(35-39 years) |
isolated CHD: NA |
risk factor |
|
4193
|
higher risk of PTB at maternal age(40-44 years) |
isolated CHD: NA |
risk factor |
|
4198
|
with JET |
isolated CHD: AVSD/TOF/VSD |
risk factor |
|
4227
|
Maternal vitamin D receptor gene Fok1 genotype: F/f |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
risk factor |
|
4228
|
Maternal vitamin D receptor gene Fok1 genotype: f/f |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
risk factor |
|
4229
|
Maternal vitamin D receptor gene Fok1 alleles: f |
isolated CHD: VSD/ASD/PDA/TGA/TOF/TAS/HLHS/DORV |
risk factor |
